News and Events

Pharmacare and Specialty Drugs Survey

October 8, 2020

This survey is being conducted to learn from Canadians their experiences accessing specialty drugs. In addition, we are asking opinions about how specialty drugs should be available in a National Pharmacare program. This feedback is very important and timely.

Alberta delays Biosimilars forced switching until January 2021 because of COVID-19. Never would be better but at least takes stress off patients and clinicians during this really challenging time.

April 6, 2020

On December 12, 2019, the Alberta government introduced the Alberta Biosimilar Initiative. This communication is to inform you the switching requirement of the Biosimilar Initiative.

Open Letter to Ontario Premier and Deputy Premier/Minister of Health

January 29, 2020

A policy being considered by your government may present risks to some patients ho will be forced to switch from a biologic medicine that is.

Canadian Strategy for Patient-Centred, Cost-Effective, Sustainable Biosimilars Access

January 14, 2020

Biosimilars Summary pdf

News and Events

Pharmacare and Specialty Drugs Survey

Alberta delays Biosimilars forced switching until January 2021 because of COVID-19. Never would be better but at least takes stress off patients and clinicians during this really challenging time.

Open Letter to Ontario Premier and Deputy Premier/Minister of Health

Canadian Strategy for Patient-Centred, Cost-Effective, Sustainable Biosimilars Access

Health Coaching in Diabetes: Empowering Patients to Self-Manage

Health Coaching Workshops

The State of Medical Lab Services is a Key Issue for Ontario Patients